Sync-Loc™, A multi-barrier Abuse Deterrent Technology Platform
ExxPharma has developed a proprietary abuse deterrent technology (“Sync-Loc™”) platform that overcomes all modes of product tampering (crushing, chewing, grinding, extraction and vaporization) and hence all modes of abuse (swallowing, snorting, injection and smoking). Sync-Loc™ utilizes a synchronized abuse deterrent mechanism that relies on physical, mechanical and chemical barriers to prevent dosage form tampering. The technology has additional features that shorten development time and prolong shelf-life of products. Products developed using Sync-Loc™ technology are expected to be granted ADF labeling designation by FDA.
Utilizes innovative formulation & process design
Employs multiple barriers of deterrence in the dosage form
Releases the active ingredient through a hybrid mechanism
Produces tablets and multiparticulates
Imparts chemical and physical stability on a drug product